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Electroconvulsive Therapy
(ECT): An Introduction for
Elder Law Professionals
Electroconvulsive therapy (ECT),
colloquially called "shock therapy," is

By Deirdre Johnston, Doug Eitel,
and W. Vaughn McCall

often denounced as barbaricby
members of the lay population.
However, it is actually a highly
efficacious treatment for depression,
which can be particularlycommon and
severe in the elderly. This discussion
illuminates the potential benefits and
risks of this controversialtreatment.

uring a recent workshop with a group
of law students on dementia and capacity issues, factors contributing to
variability in functional capacity were
discussed. These included psychiatric
& /
syndromes that might influence an elderly person's
perceptions and cognition. One important, treatable
condition is major depression, which can be particularly common and severe in the elderly. There is a
range of effective treatments available for this common illness, which, when used appropriately, can
restore functional capacity and independence. However, the students expressed firmly entrenched
negative beliefs regarding one particular treatment:
electroconvulsive therapy, or "shock therapy."
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When electroconvulsive therapy (ECT) was mentioned as a treatment option, a number of students
became animatedly vocal, denouncing ECT as brutal and barbaric. Efforts to present the students with
evidence to the contrary were met with outright skepticism. Their reaction is understandable, in light of
what one finds when attempting to obtain information regarding ECT from any source other than
mainstream scientific publications. For example, an
Internet search for ECT generates links to numerous
sites depicting disturbing images of grimacing faces
and lightning bolts.
It appears that the depiction of ECT in the popular media is still represented by images such as that
in the movie One Flew Over the Cuckoo's Nest,
which blurs the distinction between ECT and lobotomy. In fact, such images are inaccurate and
misleading. The use and effects of ECT are far different than portrayed; yet the "Cuckoo's Nest" image
is the one that dominates the public-and seemingly,
many legal professionals'-perception. It is likely that
this and similar images have contributed in some
measure to the obstruction of access to treatment by
some people who might benefit from ECT.

Indications for ECT
It is generally accepted in the medical profession that
ECT is safe and effective. There is an extensive body
of clinical and research literature supporting the use
of ECT. There are well-established indications for
its use, as well as clear guidelines for its appropriate
administration. The most common indication for
ECT is as a secondary treatment for major depression when the illness is unresponsive to
antidepressants. It is also used as a primary treatment when depression is so severe as to be life
threatening.
In addition to being an extremely valuable treatment resource in such situations, ECT also remains
the most reliable and effective primary treatment for
major depression with psychotic features.I However,
in practice, it is usually used only after other treatments have failed.2 In the elderly, there is evidence
that ECT may, in fact, be increasingly effective with
increasing age,3 and that it is well tolerated even by
persons in the over eighty, or "old-old" age group.4

Major Depression
Major depression is a serious medical illness and can
be associated with significant medical complications,
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including suicide and death from other causes. For
instance, it has been shown that depression increases
the risk for cardiac mortality--even in persons without cardiac disease at baseline.' In older individuals,
depression, similar to dementia, presents impairment
that not only affects mood, but also involves cognition and perceptions. Persons with severe depression
may become inattentive to their personal care. They
may neglect themselves by not eating or bathing, and
may become withdrawn and isolated. They may neglect to pay bills, resulting in loss of utilities or other
necessary services. These complications are more
common in the elderly than in younger adults.
Secondary medical complications may arise, necessitating emergency medical care. A profoundly
depressed person may exhibit psychomotor retardation in which response time is markedly impaired.
He or she may stare fixedly into space when being
addressed and may seem unable to understand verbal requests, commands, or instructions, giving the
appearance of having dementia. Without effective
treatment-in addition to being at risk of medical
complications including malnutrition, dehydration,
infections, falls, and the sequelae of prolonged immobility-such an individual may lose the ability to
care for him- or herself, to make decisions on his or
her own behalf, and may even be institutionalized.
Depression may also complicate dementia, aggravating the degree of cognitive impairment to the point
at which, unless the depression is treated, loss of
independence and institutionalization can occur
prematurely.

Major Depression with Psychotic Features
In severe major depression, psychotic symptoms can
develop, including delusional beliefs. Delusion is
defined as, "a false belief based on incorrect inference about external reality that is firmly sustained
despite what everyone else believes and despite what
constitutes incontrovertible and obvious proof or
evidence to the contrary." 6
In nihilistic delusions, affected persons become
convinced that everything is hopeless, that they are
doomed, even that the location that they inhabit is a
wasteland. One woman was delusionally convinced
that her body was dead, that it had been replaced
by an artificial body made of plastic, and that food
or medications introduced to this plastic body were
wasted. On the basis of this belief, she refused to
eat or to take medication, resulting in eventual
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involuntary admission to a hospital in a state of profound malnutrition.
Persecutory and paranoid delusions are more frequently seen in severe major depression. In these
situations, the affected persons may believe that they
are in physical danger from others or that people
are stealing from them. Such individuals may go to
great lengths to protect themselves from the person(s)
whom they believe to be dangerous, sometimes resulting in behavior that puts themselves and others
at risk. This may include refusing food or medications because of the belief that such offerings contain
poison, or threatening imagined assailants with
weapons. Because of the loss of motivation, energy,
and initiative that usually accompanies severe depressive illness, the persons may not act on these
beliefs.

Suicide Risk
Suicidal thoughts and actions are among the most
serious complications of major depression. The risk
of suicide, particularly in the elderly, underscores the
need for effective treatment of this disorder.
Suicide rates are highest in the geriatric population, particularly in older white males, and have been
increasing in the past decade.' Older Americans are
disproportionately likely to kill themselves. Nineteen
percent of all U.S. suicide deaths in 1997 involved
persons over the age of sixty-five, although persons
over sixty-five comprise only thirteen percent of the
U.S. population. The rate is highest in those over the
age of eighty-five. Suicide is the cause of death in 65
deaths per 100,000 persons over eighty-five: This is
approximately six times the national U.S. rate of 10.6
suicides per 100,000 populations.'
Effective treatment of depression might prevent
some of these deaths. However, no one treatment
works for everyone, and some individuals do not
respond to medication.

Treatment for Depression
Much progress has been made in recent years in the
development of safer, more effective, pharmacological treatments. A range of psychopharmacological
agents is now available, including the selective serotonin reuptake inhibitors, or SSRIs (e.g., fluoxetine,
sertraline, paroxetine, fluvoxamine) and the atypicals
(e.g., nefazadone, venlafaxine). The older medications (tricyclic antidepressants and monoamine
oxidase inhibitors), which were more toxic but also

very effective for many, are still available and may
help some of those who fail trials of the newer agents.
As noted above, there are still individuals whose
depression does not respond to medication. For these
persons, ECT can be lifesaving and can make a significant difference to the quality of life of the affected
persons and their families. Yet because of negative
perceptions of ECT, some people who may benefit
from it may not have access to it or may refuse it.
The following hypothetical illustrates the particularly
valuable role of ECT in geriatric psychiatry.

The Case of Mrs. K.L.
Mrs. K.L. is a seventy-four-year-old, married, white
female. She is the primary caregiver for her seventyeight-year-old husband, who suffers from
insulin-dependent diabetes, chronic congestive heart
failure, renal failure, and vascular dementia.
Mrs. K.L. has a history of two episodes of major
depression. One episode occurred after the birth of
her last child in 1960. The second followed an episode of influenza in 1984, during which she made a
serious suicide attempt. She was given antidepressant medication on both occasions without any
improvement, and with progression of her symptoms.
As a result, her treating physicians recommended
ECT. On both occasions she responded to a course
of three applications of the treatment. During the
episodes of depression, she was withdrawn, hostile,
had no energy or motivation, remained in bed, refused to eat, lost more than twenty pounds on each
occasion, and expressed the wish to die. Between
episodes, she was active, energetic, and very much
involved in family and community activities.
In 1997, her family noticed that she was increasingly irritable, lost interest in usual activities, and
began refusing to eat. They requested referral to a
psychiatrist after she began to express the belief that
her house was infested with poisonous molds that
she could smell, even though no one else could smell
anything. She was agitated, could not sit still long
enough to stay in church with her family, and gave
up her involvement in usual activities. Although she
continued to care for her frail husband, she felt depressed and hopeless, could not sleep at night, woke
early, and began to describe a death wish.
She was started on an antidepressant, a selective
serotonin reuptake inhibitor (SSRI) that is the standard primary treatment for major depression.
Because of the persistent delusional beliefs (the family
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had the house checked for molds, nothing was found
but the patient could not be convinced), a small dose
of an atypical antipsychotic medication (also standard treatment for delusional syndromes in the
elderly) was added and gradually increased. After
an initial improvement, her symptoms returned while
she remained on medication. A second psychiatric
opinion was sought, and recommendations followed,
but despite appropriate increases in the doses of antidepressants and antipsychotics, as well as trials of
other antidepressants, she continued to deteriorate.
She also complained of being unable to remember
things, although on careful examination, her cognitive function was intact.
As her agitation and subjective distress progressed,
she became unable to care for her husband. Her medications were reduced in case they might be contributing
to her confusion, but she continued to worsen. Her
family hired a certified nursing assistant to come into
the home to care for her and her husband, but the
patient's agitation was so severe that it became impossible for the nurse to manage Mr. L.'s care while
constantly having to reassure and redirect his wife, who,
because of her extreme agitation, was very disruptive.
The family decided, with the patient's agreement, to
place her in a nursing home, where her mood and appetite continued to deteriorate, and she became
increasingly hopeless and agitated.
At this point, although ECT had been discussed,
the patient refused to proceed with it. Medications
were tried again, with no improvement. She paced
continuously, wept, and constantly complained that
she felt terrible and she wasn't getting her medications (this was checked-she was). She began to
express suicidal ideas, requesting a knife so she could
kill herself. Finally, she was admitted on an emergency basis to Psychiatry.
While in the hospital, a further psychiatric
opinion was sought and further medications were
tried, to no avail. She was now losing weight rapidly
due to severe agitation and refusal to eat. She was
also visibly distraught, delusional toward family
and staff, unable to sit still at all, pacing day and
night, and would strike out at anyone who approached her. Her clinical appearance resembled that
of a person with dementia. She frequently expressed
suicidal ideas, and begged to be helped or to be "put
out of [her] misery," while stating at the same time,
"there is no hope, I'm done for, nothing can help
me now."
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The patient and her husband had arranged some
time previously for their son to have durable power
of attorney. As the patient's illness progressed, her
ability to participate meaningfully in decision-making deteriorated markedly. Her son sought and
obtained guardianship. He and his siblings requested
that ECT be considered, based on her history of prior
response to it. Although the patient had objected to
having ECT when it had last been discussed, expressing the delusional belief that nothing could help her,
she retained enough insight to state that something
had to be done to make her feel better, and assented
to having ECT. As is permitted under North Carolina law, her son, now her guardian, gave consent
for the treatment to proceed.
Although she had assented to proceeding with
the treatment, the patient's agitation and delusional
nihilism prevented her from participating fully in the
consent process. She received a series of eight treatments and showed little improvement (most people
show adequate improvement after six). She was not
eating, and was taking minimal oral fluids. Because
of her agitation she was unable to tolerate the placement of an intravenous line to hydrate her. In
addition, she became dehydrated and developed a
urinary tract infection and subsequently developed
pneumonia. After a conference with the treatment
team, the family requested that ECT be continued.
Mrs. K.L. had six further treatments and finally began to improve, a total of fourteen treatments in all
for this episode of depression.
After her treatments, she experienced some transient confusion but was discharged to the nursing
home. Monthly maintenance treatments were scheduled, as is commonly the practice in persons whose
depression is refractory to medication. On followup visits she continued to improve and moved back
home to care for her husband. She requested to be
allowed to drive again, as she had allowed her family to sell her car when she had been admitted to the
nursing home. Approximately three months after
discharge from the hospital, an occupational therapy
adaptive driving skills assessment was carried out,
and she was found to be capable of driving safely.
She continued to have maintenance ECT for approximately one year.
The treatments have since been tapered and
discontinued at the patient's request. She remains
on a maintenance dose of an "atypical" antidepressant (one of the newer antidepressants with a
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combination of pharmacological actions). At the time
of writing (January 2002), Mrs. K.L. remains the
primary caregiver for her husband, who has since
been diagnosed with colon cancer. Mr. L. now has a
colostomy, which Mrs. K.L. is responsible for changing several times a day. Her family says she manages
this very well. In addition, she is an avid cook and
enjoys preparing Sunday lunch for her children and
grandchildren weekly.
On examination, she is well groomed and pleasant, energetic, and speaks enthusiastically about her
many interests. Her family reports that she is back
to her "old self." Her mood is stable and her memory
and cognition are intact, although she does not remember being in the hospital. She is extremely
grateful for having had the treatment that allowed
her to return to her previous level of functioning.
She is actively involved in her church and community. In 1999, her younger brother developed a
depressive illness with similar symptoms. Because his
sister had responded well to ECT, he sought the same
treatment she received. He received six applications
of ECT, made a full recovery, and remains well.
Key Points
This case illustrates several important points:
1. Indications for ECT:
a. Mrs. K.L. was given several trials of antidepressant medications without success.
b. She had a favorable prior response to
ECT.
c. Her illness was life threatening, with unrelieved suicidality, progressive emaciation,
and was now complicated by secondary
illness (dehydration and infection).
2. Treatment strategy guided by the patient's
wishes:
She initially refused ECT during this episode of depression and agreed to take medication; the treatment team honored her
wishes until her illness became life threatening. At that point, ECT was sought as a
life-saving intervention.
3. Loss of independence:
Due to her persistent severe symptoms, she
was placed in a nursing home, was no longer
able to drive, was unable to participate in
her usual activities, and was unable to look
after her husband. She was totally dependent

on others for her care.
4. Competence to consent:
a. As her depression became more severe,
she developed delusions of hopelessness
and was unable to comprehend that anything could help her. On this basis she
refused ECT.
b. Her son obtained guardianship, and
sought ECT on her behalf after consultation with other family members and the
treatment team. He gave consent for the
treatment to proceed (under North Carolina law, a guardian may give consent for
ECT).
5. Good outcome:
She recovered from her depression after a
greater than usual number of treatment applications and is now fully functional in her
home and community. It has long been evident clinically, and recent research has
demonstrated, that ECT is associated with
improvement in function and in mood.9

Indications and Standards for the Use of ECT
The Surgeon General's 1999 Report on Mental
Health stated that, "on balance, the evidence supports the conclusion that modern ECT is among those
treatments effective for the treatment of select severe mental disorders, when used in accord with
current standards of care, including appropriate informed consent."10
The American Psychiatric Association (APA) has
presented recommendations on the practice of ECT
since 1978, when it established the APA Task Force
on ECT. This body has developed regularly updated
guidelines, based on continuous review of the literature regarding the indications for use and application
of ECT. The most recent update was released in
2001.11 Principal diagnostic indications, based on
either compelling data supporting the efficacy of ECT
or a strong consensus in the field among experienced
clinicians, are:
1. Unipolar major depression, including major
depression, single episode, and major depression, recurrent;
2. Bipolar major depression, including bipolar
disorder, depressed, and bipolar disorder,
mixed;
3.

Mania;

ARTICLE I Electroconvulsive Therapv (ECT): An Introduction for Elder Law Professionals

4. Schizophrenia, where the psychotic symptoms are of abrupt onset, when the illness is
of the catatonic type, or where there is a history of a favorable response to ECT; and
5. Schizoaffective disorder, a schizophrenia-like
illness in which there is a pronounced mood
component.
The APA task force recommends that ECT not
be reserved for use as a "last resort" in cases of recurrent depression where there has been a lengthy
first episode with failure to respond to medications.
Doing so may deprive patients of an effective treatment resulting in protracted suffering. It has been
shown that exposure to episodes of longer duration
may contribute to treatment resistance. 12
Major depression is a recurrent illness, and ECT is
not a "curative" procedure. It is used to treat an episode of depression. However, maintenance treatments,
usually once a month, can prevent recurrence of depression. Also, if ECT has been effective for previous
episodes of depression, a good response is likely if used
to treat subsequent episodes. In addition, as with pharmacological treatments, a family history of response
to ECT is often associated with increased likelihood of
a good response. This occurred in the case of Mrs.
K.L.'s brother, whose symptoms were very similar to
his sister's and who made a good recovery with ECT
after having had no response to trials of several different antidepressants.

Description of the ECT Procedure
In accordance with the 1999 recommendations of
the American Society of Anesthesiologists Task Force
on Perioperative Fasting,13 the patient fasts for six
to eight hours before the procedure (usually starting
at midnight the night before). Prior to the treatment,
the nurse confirms that the patient has not had anything to eat or drink and prepares him or her for
treatment. The team, usually consisting of psychiatrist, anesthesiologist, and a nurse, are present during
the procedure.
The psychiatrist speaks with the patient prior to
the treatment and reviews the medical record as well
as any new information (e.g., medication changes or
new symptoms). When the patient is ready, a shortacting intravenous anesthetic is administered along
with a short-acting muscle relaxant. A protective
mouthpiece is carefully inserted to prevent the
patient's teeth, tongue, and other oral structures from
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injury, as application of the stimulus causes a reflex
contraction of the jaw muscles. This contraction is
produced by a direct action of the stimulus on these
muscles, and not by the seizure itself. A pharmacological muscle relaxant is used to prevent muscle
contraction occurring during the seizure in order to
minimize the risk of musculoskeletal injury.
The induced seizure activity, usually lasting thirty
to sixty seconds, is monitored by continuous
electroencephalogram (EEG), as there is minimal
visible muscular contraction to indicate that a seizure is taking place. The anesthesiologist ensures that
an airway is maintained throughout the procedure
and supports the patient's breathing, monitoring
oxygenation, for the brief duration of the seizure and
the period of muscle relaxation, between two to five
minutes for most patients. A brief electrical stimulus
(measured in milliseconds) is delivered via electrodes
placed either unilaterally on the non-dominant hemisphere, or bilaterally. In humans, one hand, foot, and/
or eye-usually the right-is dominant or preferred
over the other. The contra-lateral cerebral hemisphere
controls the function of that side of the body and is
referred to as the dominant hemisphere. The opposite side of the brain is called the non-dominant
hemisphere. Unilateral non-dominant hemisphere
electrode placement is perceived to be less likely to
be associated with confusion following treatment,
therefore it is usually used initially but may be
changed to bilateral over the course of the treatments
if the patient is not experiencing an adequate therapeutic response. However, recent research suggests
that with high stimulus doses, the advantage of
choosing the non-dominant hemisphere may
disappear.
Most patients begin to feel better after three treatments and are recovered after six. There is
considerable individual variability in the number of
treatments needed, and some patients may require
ten or more treatments.

Adverse Effects of ECT
All effective medical treatments are associated with
some adverse effects, including ECT. However, as
has been noted, the popular media have overstated
the range and severity of the adverse effects of ECT,
which are usually mild and transient. The most common adverse effect is a headache following the
treatment, which usually subsides within a few
hours and can be alleviated by a mild pain-relieving
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medication such as acetaminophen if needed. Some
people may incur abrasions or lacerations to the
tongue or cheeks, or dental injuries, during the procedure, usually if the mouthpiece is inappropriately
placed or becomes displaced during treatment. Musculoskeletal injuries are uncommon since the
introduction of muscle relaxants. However, muscle
soreness is a common transient symptom and is due
to the effects of the muscle relaxant. Prolonged seizures, lasting more than three minutes, or status
epilepticus, in which the seizure persists for longer
than thirty minutes, are rare complications. This is
more likely to occur in patients receiving medication that lowers the seizure threshold. Precautions
are taken (e.g., stopping or omitting doses of the
medication prior to ECT) to prevent this.
Delayed recovery of spontaneous respiration can
occur in rare instances. If this occurs, the anesthesiologist continues to support respiration until the
patient recovers. Some elderly patients experience a
period of delirium immediately following ECT. This
resolves spontaneously within a few hours. In a small
minority of patients, mania may develop over the
course of ECT. This usually happens in patients with
bipolar disorder and is treated in the same way as an
episode of mania occurring spontaneously. More
commonly, many people experience a disruption of
short-term memory for the period prior to and during the series of treatments.
The ability to learn and retain new information
may be disrupted during the treatments, but returns
to normal within two to three weeks. 4 Some memory
loss for the period immediately prior to and during
the series of treatments may be permanent. However, ECT does not cause structural damage to the
brain.15
When mortality occurs during ECT, it is usually
a result of adverse cardiovascular effects. Therefore,
the patient is assessed carefully for cardiovascular
risk factors prior to ECT. A cardiologist is consulted,
the risks and benefits of proceeding with the treatment in the presence of an identified risk factor
are reviewed with the patient, and preventive measures are taken if it is agreed that it is necessary to
proceed.

Consent for ECT
Physicians are required to obtain informed consent from their patients before starting ECT.'6 They
are expected to summarize the mechanics of the
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procedure, its indication, reasonable treatment alternatives, and potential side effects and risks. The
patient is also informed of the right to refuse treatment and to revoke consent at any time. Some states,
such as Texas,17 require a more comprehensive disclosure. These additional disclosures can include
discussions about the degree, duration, and probability of the potential side effects, especially noting
memory loss and death.
As our patient population becomes more culturally diverse, some states have required that consent
forms be written and explained in the patient's primary language. Legislators may also require
safeguards for obtaining consent from the hearing
and visually impaired. At the patient's request, family members are included in discussions and often
witness the consent form. Physicians are typically
thorough in preserving documentation of consent
because ECT may be associated with transient
memory deficits that can cause some patients to forget such discussions.
Once the decision has been made to treat the
patient with ECT, the attending physician orders Xrays, lab work, and cardiology and anesthesiology
consults. If any additional risks are detected, the
physician discusses these risks with the patient. If
the risks are deemed to outweigh the likely benefits
of ECT, it may be decided not to pursue ECT and to
try an alternate treatment. If it is felt that the likely
therapeutic effect of ECT outweighs the risks, then
the consent issue is revisited with the patient, and a
new consent form is signed. Some states, such as
Florida," add a second layer of precaution by requiring a non-treating physician to review the
medical record and agree to the proposed ECT.

Capacity to Consent
In general, competent patients who consent to or
refuse ECT are easily managed according to their
expressed desires. Consent becomes more complicated when patients cannot understand their medical
conditions or the proposed procedure.15 This is not
unusual among the geriatric psychiatric population,
and is frequently the very cause of the hospital admission. Numerous states have legislated safeguards
to help physicians and families balance the risks and
benefits of ECT under such conditions.
First, many states regulate the process for
determining capacity. Requirements range from
informal bedside evaluations to complex and time-
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consuming court hearings. 2 0 For example, Connecticut2' requires the head of the hospital and two
qualified physicians to agree that the patient is incapable of providing informed consent. Virginia
authorizes a judge to receive evidence to determine
whether a patient is incapable of making or communicating an informed decision. 2 2 While the latter
method adds an additional safeguard for the patient,
there is some trade-off in terms of cost and expeditious relief of acute, distressful psychiatric symptoms.

Substituted Judgment
Second, many states have specified the people who
can consent on behalf of an incompetent patient. For
example, Alaska 23 and Michigan 24 authorize ECT if
the patient expressly affirmed such treatment in an
advance directive. No court involvement is required
prior to initiating treatment. Michigan also recognizes a guardian's consent if two psychiatrists concur
with the decision to administer ECT. North Carolina authorizes consent from the patient's legally
responsible person, health care power of attorney,
or pursuant to the patient's consent in an advance
instruction for mental health treatment. 25 Utah 26 and
Iowa27 allow family members as well as guardians
to consent without court interference.
The District of Columbia recognizes, in order of
priority, an attorney-in-fact, guardian, spouse, adult
child, parent, adult sibling, religious superior, and
nearest relative.28 Any of these representatives, however, must obtain a court order authorizing them to
consent. Wyoming affirmatively disallows attorneysin-fact from consenting to ECT and only recognizes
court appointed guardians.29 Wyoming also requires
the appointment of a separate guardian ad litem and
conducts a court hearing before allowing the guardian to consent.3 0 Finally, North Dakota allows
guardians to consent without prior approval by the
court.3" The presumption is that these representatives have already been screened as persons who will
advocate for the best interests of the patient and are
accountable to the court, unlike attorneys-in-fact.
At least one state, Missouri, 3 2 permits involuntary ECT over the objections of a voluntarily
admitted patient. Counsel must represent the patient
at a full hearing before the court can act. Medical
staff must demonstrate by clear and convincing evidence that the patient will enjoy significant
improvement without serious functional harm and
that there is no less drastic treatment alternative. The
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court is careful to prescribe a limited number of convulsive treatments over a specified period of time.
South Dakota3 3 and Virginia 3 4 also permit court-authorized ECT over the patient's objection for
involuntarily committed patients.
Although not the focus of this article, many states
have enacted special legislation concerning the use
of ECT on children. For example, Texas forbids ECT
being used on any person younger than sixteen years
of age.3 1 Of relevance to some geriatric patients,
Missouri forbids the use of ECT on developmentally
disabled patients. 36 Minnesota37 and Ohio38 legislate
procedural safeguards before using ECT on this
population. Perhaps the presumption is that substituted judgment is more difficult to determine with
these patients. However, these states may be denying or delaying a valuable treatment alternative for
recalcitrant patients.

Reporting Requirements
Some states go further to improve patient care by
legislating reporting requirements. Statutes range
from mandating the maintenance of consent forms
in the medical record (New Jersey)3 9 to the submission of detailed reports. For example, Illinois 40
demands quarterly reports that include the number
of patients who gave informed consent, number of
patients who received ECT without informed consent, emergency ECTs, and any adverse reactions or
autopsy findings. It is assumed that such detailed
reports prevent abuse of ECT and promote continued improvements in care.

Emergency ECT
Finally, some states allow for ECT without informed consent under life-threatening conditions.
Louisiana permits emergency treatments by authority of the facility director in consultation with two

physicians. 4 1

Summary
It is hoped that this article clarifies some of the issues misrepresented by inaccurate and sensationalized media images (apparently still dominated by
such images as those in the movie One Flew Over
the Cuckoo's Nest) in order to demystify this much
maligned, yet effective treatment for such a serious,
disabling, and common illness as major depression.
Readers are referred to the American Psychiatric Association Task Force on ECT publication,
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The Practice of Electroconvulsive Therapy, Second
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Edition, for a more detailed account of the issues
discussed. A hypothetical case history is described
to illustrate the current standards and indications
for ECT, along with a description of the procedure
and review of adverse effects. Consent and competency issues as applied in different states are reviewed.
It is clear that a considerable degree of variability
exists nationwide. Such variability results in lack of

uniformity of access to a treatment that can be lifesaving.
Thankfully, the "Cuckoo's Nest" era is long past.
It does a grave disservice to many afflicted by severe
depression-the most severely affected and at highest risk being the elderly-to allow such images to
continue to dominate the public perception of ECT,
and possibly influence the thinking underlying some
of the laws that govern access to it.
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